España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Quest Diagnostics
DGX
NYSE
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$146.01
0
0.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Q2 2024 earnings tomorrow on Tue Jul 23rd before the market open
Quest Diagnostics (DGX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Quest Diagnostics (NYSE:DGX) Stock
Quest Diagnostics Stock (NYSE: DGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, July 21, 2024
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
Shanthi Rexaline
Friday, July 19, 2024
Quest Diagnostics Says Patient Services & Cus...
Benzinga Newsdesk
Quest Diagnostics Says Taking Swift Action To...
Benzinga Newsdesk
Thursday, July 18, 2024
EXCLUSIVE: Lisata Therapeutics Tells Benzinga...
Benzinga Newsdesk
EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy
Vandana Singh
Monday, July 15, 2024
Quest Diagnostics Set to Acquire OhioHealth's Lab Services
Zacks
Truist Securities Maintains Hold on Quest Dia...
Benzinga Newsdesk
Wednesday, July 10, 2024
Quest Diagnostics To Acquire Outreach Laborat...
Benzinga Newsdesk
Citigroup Upgrades Quest Diagnostics to Buy, ...
Benzinga Newsdesk
Friday, July 05, 2024
Quest Diagnostics to Expand in Canada With LifeLabs Buyout
Zacks
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
Benzinga Insights
Baird Maintains Neutral on Quest Diagnostics,...
Benzinga Newsdesk
Wednesday, July 03, 2024
Quest Diagnostics Announces Definitive Agreem...
Benzinga Newsdesk
Thursday, June 27, 2024
How Is The Market Feeling About Quest Diagnostics?
Benzinga Insights
Wednesday, June 26, 2024
Quest Diagnostics And Allina Health Announce ...
Benzinga Newsdesk
Tuesday, June 11, 2024
Quest Diagnostics Completes Acquisition Of Se...
Benzinga Newsdesk
Monday, June 10, 2024
Peering Into Quest Diagnostics's Recent Short Interest
Benzinga Insights
Friday, May 31, 2024
Study Finds ctDNA Testing For Minimal Residua...
Benzinga Newsdesk
Thursday, May 30, 2024
Analyst Scoreboard: 7 Ratings For Quest Diagnostics
Benzinga Insights
JP Morgan Maintains Neutral on Quest Diagnost...
Benzinga Newsdesk
Friday, May 24, 2024
How Is The Market Feeling About Quest Diagnostics?
Benzinga Insights
Wednesday, May 15, 2024
Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High
Vandana Singh
Wednesday, May 01, 2024
Quest Diagnostics Announced A Multi-faceted C...
Benzinga Newsdesk
Monday, April 29, 2024
Quest Diagnostics shares are trading higher. ...
Benzinga Newsdesk
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Shanthi Rexaline
Thursday, April 25, 2024
Barclays Maintains Equal-Weight on Quest Diag...
Benzinga Newsdesk
Wednesday, April 24, 2024
Peering Into Quest Diagnostics's Recent Short Interest
Benzinga Insights
Citigroup Maintains Neutral on Quest Diagnost...
Benzinga Newsdesk
UBS Maintains Neutral on Quest Diagnostics, R...
Benzinga Newsdesk
Truist Securities Maintains Hold on Quest Dia...
Benzinga Newsdesk
The Analyst Landscape: 5 Takes On Quest Diagnostics
Benzinga Insights
Mizuho Maintains Buy on Quest Diagnostics, Ra...
Benzinga Newsdesk
Tuesday, April 23, 2024
Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic
Vandana Singh
Quest Diagnostics shares are trading higher a...
Benzinga Newsdesk
Earnings Scheduled For April 23, 2024
Benzinga Insights
Quest Diagnostics Forecasts FY2024 Adjusted E...
Benzinga Newsdesk
Quest Diagnostics Expects FY2024 Revenues Of ...
Benzinga Newsdesk
Quest Diagnostics Q1 2024 Adj EPS $2.04 Beats...
Benzinga Newsdesk
Monday, April 22, 2024
Quest Diagnostics Adds p-tau217 Blood Biomark...
Benzinga Newsdesk
US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'
Shanthi Rexaline
Sunday, April 21, 2024
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Shanthi Rexaline
Wednesday, March 20, 2024
Key Takeaways From Quest Diagnostics Analyst Ratings
Benzinga Insights
Truist Securities Reiterates Hold on Quest Di...
Benzinga Newsdesk
Monday, March 18, 2024
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
Adam Eckert
Tuesday, March 05, 2024
(DGX) - Analyzing Quest Diagnostics's Short Interest
Benzinga Insights
Monday, February 26, 2024
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
Benzinga Insights
Leerink Partners Initiates Coverage On Quest ...
Benzinga Newsdesk
Wednesday, February 21, 2024
Quest Diagnostics and Instacart Collaborate t...
Benzinga Newsdesk
Tuesday, February 13, 2024
Quest Diagnostics Launch MelaNodal Predict Te...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch